To determine if the effects of SGLT2 inhibition on hypertension and circulatory factors observed in our mouse model were similar to those of established antihypertensive treatments, we re-examined a human cohort consisting of normotensive, untreated hypertensive and treated hypertensive subjects, in which oxidative stress had previously been studied [9]. Here, SLC5A2 is linked to Hypertension.